Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/11 → 1/1/15 |
Funding
- Pfizer, Inc.: $126,578.20
Protocol B1971011: A Phase 2, Randomized, Single-Blind Trial, To Asess the Safety, Tolerability and Immunogenicity of Gardasil Vaccine and rLP2086 Vaccine When Administered Concomitantly in Healthy Subjects Aged >/= 11 to </=17 Years
- Rupp, Richard (PI)
Project: Research project